tildrakizumab-asmn
tildrakizumab-asmn is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including ILUMYA. Available dosage form: injection, solution.
Drug Details
- Generic Name
- tildrakizumab-asmn
- Brand Names
- ILUMYA
- Application Number
- BLA761067
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- TILDRAKIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE ILUMYA ® is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ILUMYA is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ( 1 )